JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002395200 on July 11, 2000

J. Biol. Chem., Vol. 275, Issue 41, 32057-32065, October 13, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/41/32057    most recent
M002395200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Law, P.-Y.
Right arrow Articles by Loh, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Law, P.-Y.
Right arrow Articles by Loh, H. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Deltorphin II-induced Rapid Desensitization of delta -Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor*

Ping-Yee Law, Odile Maestri-El Kouhen, Jonathan Solberg, Wei Wang, Laurie J. Erickson, and Horace H. Loh

From the Department of Pharmacology, the University of Minnesota Medical School, Minneapolis, Minnesota 55455-0217

Similar to other G protein-coupled receptors, rapid phosphorylation of the delta -opioid receptor in the presence of agonist has been reported. Hence, agonist-induced desensitization of the delta -opioid receptor has been suggested to be via the receptor phosphorylation, arrestin-mediated pathway. However, due to the highly efficient coupling between the delta -opioid receptor and the adenylyl cyclase, the direct correlation between the rates of receptor phosphorylation and receptor desensitization as measured by the adenylyl cyclase activity could not be established. In the current studies, using an ecdysone-inducible expression system to control the delta -opioid receptor levels in HEK293 cells, we could demonstrate that the rate of deltorphin II-induced receptor desensitization is dependent on the receptor level. Only at receptor concentrations <= 90 fmol/mg of protein were rapid desensitizations (t1/2 <10 min) observed. Apparently, deltorphin II-induced receptor desensitization involves cellular events in addition to receptor phosphorylation. Mutation of Ser363 in the carboxyl tail of the delta -opioid receptor to Ala completely abolished the deltorphin II-induced receptor phosphorylation but not the desensitization response. Although the magnitude of desensitization was attenuated, the rate of deltorphin II-induced receptor desensitization remained the same in the S363A mutant as compared with wild type. Also, the S363A mutant could internalize in the presence of deltorphin II. Only when the agonist-induced clathrin-coated pit-mediated receptor internalization was blocked by 0.4 M sucrose that the deltorphin II-induced receptor desensitization was abolished in the S363A mutant. Similarly, 0.4 M sucrose could partially block the agonist-induced rapid desensitization in HEK293 cells expressing the wild type delta -opioid receptor. Taken together, these data supported the hypothesis that rapid desensitization of the delta -opioid receptor involves both the phosphorylation and the internalization of the receptor.


* This work was supported in part by National Institutes of Health Grants DA07339, DA11806, and DA00564 and the F. Stark Fund of Minnesota Medical Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Gupta, R. Rozenfeld, I. Gomes, K. M. Raehal, F. M. Decaillot, L. M. Bohn, and L. A. Devi
Post-activation-mediated Changes in Opioid Receptors Detected by N-terminal Antibodies
J. Biol. Chem., April 18, 2008; 283(16): 10735 - 10744.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Qiu, H. H. Loh, and P.-Y. Law
Phosphorylation of the {delta}-Opioid Receptor Regulates Its beta-Arrestins Selectivity and Subsequent Receptor Internalization and Adenylyl Cyclase Desensitization
J. Biol. Chem., August 3, 2007; 282(31): 22315 - 22323.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Navratilova, S. Waite, D. Stropova, M. C. Eaton, I. D. Alves, V. J. Hruby, W. R. Roeske, H. I. Yamamura, and E. V. Varga
Quantitative Evaluation of Human {delta} Opioid Receptor Desensitization Using the Operational Model of Drug Action
Mol. Pharmacol., May 1, 2007; 71(5): 1416 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Zhao, H. H. Loh, and P. Y. Law
Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor Internalization
Mol. Pharmacol., April 1, 2006; 69(4): 1421 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. M. Jutkiewicz, S. T. Kaminsky, K. C. Rice, J. R. Traynor, and J. H. Woods
Differential Behavioral Tolerance to the {delta}-Opioid Agonist SNC80 ([(+)-4-[({alpha}R)-{alpha}-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley Rats
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. A. Claude-Geppert, J. Liu, J. Solberg, L. J. Erickson-Herbrandson, H. H. Loh, and P.-Y. Law
Antagonist Efficacy in MORS196L Mutant Is Affected by the Interaction between Transmembrane Domains of the Opioid Receptor
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 216 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Audet, M. Paquin-Gobeil, O. Landry-Paquet, P. W. Schiller, and G. Pineyro
Internalization and Src Activity Regulate the Time Course of ERK Activation by Delta Opioid Receptor Ligands
J. Biol. Chem., March 4, 2005; 280(9): 7808 - 7816.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Mollereau, H. Mazarguil, J.-M. Zajac, and M. Roumy
Neuropeptide FF (NPFF) Analogs Functionally Antagonize Opioid Activities in NPFF2 Receptor-Transfected SH-SY5Y Neuroblastoma Cells
Mol. Pharmacol., March 1, 2005; 67(3): 965 - 975.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Pineyro, M. Azzi, A. deLean, P. W. Schiller, and M. Bouvier
Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human {delta}-Opioid Receptor with an Inverse Agonist
Mol. Pharmacol., January 1, 2005; 67(1): 336 - 348.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Marie, I. Lecoq, P. Jauzac, and S. Allouche
Differential Sorting of Human {delta}-Opioid Receptors after Internalization by Peptide and Alkaloid Agonists
J. Biol. Chem., June 13, 2003; 278(25): 22795 - 22804.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. A. Eisinger, H. Ammer, and R. Schulz
Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization
J. Neurosci., December 1, 2002; 22(23): 10192 - 10200.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Zhang, J. Li, J.-G. Li, and L.-Y. Liu-Chen
(-)U50,488H [(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] Induces Internalization and Down-Regulation of the Human, but not the Rat, kappa -Opioid Receptor: Structural Basis for the Differential Regulation
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1184 - 1192.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Gicquiaux, S. Lecat, M. Gaire, A. Dieterlen, Y. Mely, K. Takeda, B. Bucher, and J.-L. Galzi
Rapid Internalization and Recycling of the Human Neuropeptide Y Y1 Receptor
J. Biol. Chem., February 15, 2002; 277(8): 6645 - 6655.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. M.-E. Kouhen, G. Wang, J. Solberg, L. J. Erickson, P.-Y. Law, and H. H. Loh
Hierarchical Phosphorylation of delta -Opioid Receptor Regulates Agonist-induced Receptor Desensitization and Internalization
J. Biol. Chem., November 17, 2000; 275(47): 36659 - 36664.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.